Analysts Are Bullish on Top Technology Stocks: ServiceNow (NOW), Gorilla Technology Group Inc. (GRRR)

Analysts from Jefferies and Northland Securities reiterated Buy ratings on ServiceNow (NOW) and Gorilla Technology Group (GRRR), with price targets of $140 and $40, respectively. ServiceNow's consensus target is $143.41, a 4.1% upside. Gorilla Technology's consensus target is $34.60. ChronoScale (CHRN) also received a Buy rating with a $32 target.

Original reporting
Published Oct 3, 2026, 1:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Are Bullish on Top Technology Stocks: ServiceNow (NOW), Gorilla Technology Group Inc. (GRRR) — source image
Decision brief

The 30-second read

$NOWBullishMed
01

Why it matters

The upgrades provide fresh price targets that could prompt short‑term buying, especially for the larger cap ServiceNow.

02

Market read

Analyst upgrades with new price targets create modest trading opportunities in the tech sector.

03

What to watch

No new earnings or fundamental data accompany the rating changes.

Relevance 6/10Novelty 5/10Timing: today

Background

Three analysts issued bullish ratings and higher price targets for ServiceNow, Gorilla Technology Group, and ChronoScale.

Company-level read

Ticker impact

$NOWBullishMedium confidence
Context

Jefferies analyst Samad Samana maintained a Buy rating on ServiceNow and set a new price target of $140.

Expected impact

likely upward pressure as investors price in the $140 target

Evidence & confidence

Buy rating and a target above current price suggest short‑term buying interest.

$GRRRBullishMedium confidence
Context

Northland Securities reiterated a Buy rating on Gorilla Technology Group with a $40 price target.

Expected impact

potential upside as market absorbs the $40 target

Evidence & confidence

Analyst endorsement and a target well above the recent close imply positive sentiment.

$CHRNBullishMedium confidence
Context

Northland Securities reiterated a Buy rating on ChronoScale with a $32 price target.

Expected impact

moderate upward pressure as investors consider the $32 target

Evidence & confidence

Buy rating and target above last close suggest modest buying interest.

Market effects

Positive analyst sentiment may lift broader technology sector sentiment.

U.S. technology stocks could see modest gains.

Limited to investors tracking U.S. tech equities.

Counterpoint

Analyst targets may be overly optimistic given recent market volatility.

Key entities

  • ServiceNow

    U.S. cloud‑software provider

  • Gorilla Technology Group

    Technology firm listed on U.S. exchange

  • ChronoScale

    Technology company listed on U.S. exchange

Related articles

$CHRNMed

ChronoScale Expands AI Pipeline With $1 Billion Revenue Run Rate In Sight

ChronoScale Holdings (CHRN) shares rose after expanding AI infrastructure contracts, projecting a $1 billion annualized revenue run rate by Q3 2027. The company also completed the sale of its Ekso Bionics business. CHRN is trading at $20.33, above its 20-day and 100-day SMAs but below the 50-day SMA. Analysts rate CHRN as Strong Buy with an average price target of $32.

$CHRNHighAI 8/10

ChronoScale stock jumps on $1B revenue target from AI deals

ChronoScale Corp (CHRN) shares rose 3% after-hours after announcing deals expected to reach $1B annualized revenue run rate by Q3 2027. The AI infrastructure provider signed a contract extension and new customer agreement, though revenue is subject to deployment and capital risks. The company also sold its Ekso Bionics unit to focus on core AI infrastructure business.

$CHRNMed

ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit

ChronoScale (NASDAQ: CHRN) announced new AI infrastructure agreements, expected to drive its annualized revenue run rate to $1 billion by Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus on its core AI infrastructure business. ChronoScale's CEO highlighted the importance of these agreements in validating demand and growing alongside customers.